A Pharmacokinetic Study of Intravenous and Intranasal Oxytocin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

November 1, 2023

Study Completion Date

November 1, 2023

Conditions

Healthy Volunteer Study

Interventions

DRUG

intravenous oxytocin

Oxytocin given by intravenous route

DRUG

intranasal oxytocin

Oxytocin given by intranasal administration

Trial Locations (1)

Wake Forest Baptist Health, Winston-Salem

All Listed Sponsors

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT05672667 - A Pharmacokinetic Study of Intravenous and Intranasal Oxytocin in Healthy Subjects | Biotech Hunter | Biotech Hunter